Softgel Capsule Market Synopsis

Softgel Capsule Market Size Was Valued at USD 4.97 Billion in 2023 and is Projected to Reach USD 9.32 Billion by 2032, Growing at a CAGR of 7.23% From 2024-2032.

Softgel capsules are a type of oral dosage form composed of a gelatin or non-gelatin shell containing a liquid, semi-solid, or suspension formulation. These capsules are typically smooth, easy to swallow, and offer advantages such as enhanced bioavailability, improved stability, and precise dosing. They are commonly used for delivering pharmaceutical drugs, dietary supplements, and cosmeceutical formulations. Softgel capsules are favored for their versatility, allowing for the customization of formulations to meet specific patient needs.

The Softgel Capsule is increasing demand for convenient and easy-to-swallow oral dosage forms. These capsules, enclosed in a gelatin or non-gelatin shell and filled with liquid or semi-solid formulations, are gaining popularity across pharmaceuticals, nutraceuticals, and cosmeceuticals industries. They have smooth texture and ease of ingestion and are widely preferred by consumers, contributing to their widespread adoption.

• The Softgel Capsule market benefits from technological advancements that enhance product stability, bioavailability, and customization options. Pharmaceutical companies utilize softgel capsules to deliver both prescription and over-the-counter medications effectively. The nutraceutical sector is also influenced by these capsules for delivering dietary supplements, vitamins, and herbal extracts to its growing health-conscious consumer base.
• Furthermore, the cosmeceutical industry utilizes softgel capsules to capture skincare and beauty formulations, capitalizing on consumer preferences for innovative and convenient beauty products. With various expanding applications and continual advancements, the Softgel Capsule market is rising for sustained growth in the predictable future.

Softgel Capsule Market Trend Analysis

Growing Demand for Natural and Vegetarian Alternatives

• There is a growing demand for ethical and dietary concerns perception for health and wellness in consumers. The is a rising demand for Vegetarian and vegan products free from animal-derived ingredients, such as traditional gelatin-based softgels. Consumers also have allergies or sensitivities to animal-derived ingredients, making non-gelatin alternatives safer. Traditional gelatin production has environmental concerns, such as animal farming and land-use issues.
• These concerns have created manufacturers an opportunity to develop a wider variety of non-Gelatin softgel options made from plant-based materials like carrageenan, pullulan, and starch-glycerin. Technological advancements are also enabling the development of improved non-Gelatin capsules with superior stability, functionality, and release properties. This diversification of the softgel capsule market presents a significant growth opportunity, especially in regions with high adoption of vegetarian and vegan lifestyles. The softgel capsule manufacturers are capitalizing on the trend by offering a diverse range of natural and vegetarian formulations, and the evolving preferences of consumers in the market.

The Rising Demand for Personalization and Customization

• The rising demand for personalization and customization is due to consumers increasingly preference products tailored to their specific needs and preferences. Softgel capsules offer a versatile platform for customization, allowing manufacturers to formulate precise dosages and target-specific drug delivery, enhancing their appeal to consumers. This ability to tailor formulations to individual requirements can lead to increased consumer satisfaction and loyalty, driving sales and strengthening brand positioning.
• The demand for personalized healthcare products continues to grow, and there is an increase in the need for raw materials suitable for customized softgel formulations. Manufacturers can capitalize on this trend by sourcing high-quality ingredients that meet consumer demands for natural, vegetarian, or other specialized formulations. By offering a diverse range of customizable options, softgel capsule manufacturers can better address the evolving needs of consumers and differentiate themselves in a competitive market landscape, ultimately driving growth and profitability.

Softgel Capsule Market Segment Analysis:

Softgel Capsule Market Segmented based on Product Type, Source Type and Application.

By Product Type, Gelatin Softgel Capsules segment is expected to dominate the market during the forecast period

• The Gelatin capsules segment is widely used in pharmaceuticals and dietary supplements for their versatility, cost-effectiveness, and comfort of manufacturing. Gelatin, derived from animal collagen, possesses excellent gelling properties, ensuring the integrity of the capsule shell and protecting the encapsulated contents from environmental degradation. The gelatin softgels offer enhanced bioavailability, ensuring efficient absorption of the contained active ingredients by the body.
• Its characteristic makes them highly desirable for formulations requiring precise dosage delivery and rapid onset of action. The gelatin softgel capsules exhibit excellent stability, maintaining their structural integrity over extended periods, which is crucial for shelf-life and consumer trust. These attributes contribute to the dominance of the Gelatin Softgel Capsules segment in the Softgel Capsule market,

By Source Type, the Animal-based segment held the largest share of 83% in 2022

• The animal-based softgel capsules are typically sourced from gelatin, which is derived from collagen found in the skin, bones, and connective tissues of animals. Gelatin offers superior properties such as excellent gelling ability, stability, and compatibility with a wide range of active pharmaceutical ingredients (APIs), making it a preferred choice for encapsulation in the pharmaceutical and nutraceutical industries.
• The Animal-based softgel capsules are widely favored due to their perceived safety and efficacy. Gelatin has a long history of safe use in pharmaceutical formulations and is recognized by regulatory authorities worldwide. Animal-based capsules' cost-effectiveness and availability of raw materials, allowing manufacturers to maintain a stable supply chain and competitive pricing help strengthen their market share in the forecast period.

Softgel Capsule Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast Period

• The Asia Pacific region is experiencing industrialization, and urbanization, in the healthcare sector due to developing economies like China, and India. The growing health concerns, rising disposable incomes, and proactive government initiatives set the stage for substantial market expansion.
• The Asia Pacific region benefits from a flourishing scientific base and enhanced pharmaceutical manufacturing capabilities, supported by strategic investments and technological advancements. The regional ecosystem supports innovation and product development and enhances the region's competitiveness in global pharmaceutical markets.
• The presence of a vast patient pool in several Asian countries emphasizes the region's significance as a crucial market for softgel capsules. The presence of global pharmaceutical manufacturers is strategically establishing manufacturing facilities in the Asia Pacific, region and growth potential and cost efficiencies these factors place the Asia Pacific as the dominant in the softgel capsules market over the forecast period.

Softgel Capsule Market Top Key Players:

• Catalant Inc. (USA)
• Best Formulations Inc. (USA)
• Amneal Pharmaceuticals (USA)
• Capsugel (Lonza) (USA)
• Robinson Pharma Inc. (USA)
• Thermofisher Scientific Inc. (USA)
• Captek Softgel International Inc. (USA)
• Roquette (France)
• Curtis Health Caps (Poland)
• DCC Plc. (Ireland)
• Procaps Groups (Colombia)
• Aenova Group (Germany)
• PB Leiner (Germany)
• Fuji Capsule Co., Ltd. (Japan)
• Sirio Pharma Co. (China), and Other Major Players.

Key Industry Developments in the Softgel Capsule Market:

• In May 2024, Roquette revealed its latest innovation: LYCAGEL® Flex, a hydroxypropyl pea starch premix tailored for nutraceutical and pharmaceutical softgel capsules. This cutting-edge product, based on Roquette’s pioneering pea starch technology, eliminates the need for plasticizers. Offering manufacturers flexibility in formulation customization, LYCAGEL® Flex sets new benchmarks in quality, stability, and performance for plant-based softgels.
• In December 2023, Amneal Pharmaceuticals, in collaboration with Strides Pharma Science Limited, unveiled the launch of Icosapent ethyl acid soft gel capsules, branded as VASCEPA. Strides Pharma granted an in-license for the medication, marking its entry into the market in the fourth quarter of 2023. These capsules, containing ethyl ester of eicosapentaenoic acid (EPA), aim to serve as a dietary supplement for adults with severe hypertriglyceridemia (≥ 500 mg/dL).

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. SOFTGEL CAPSULE MARKET BY PRODUCT TYPE (2017-2032)
   1. SOFTGEL CAPSULE MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. GELATIN SOFTGEL CAPSULE
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. NON-GELATIN SOFTGEL CAPSULE
7. SOFTGEL CAPSULE MARKET BY SOURCE TYPE (2017-2032)
   1. SOFTGEL CAPSULE MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. NON-ANIMAL-BASED
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. ANIMAL-BASED
8. SOFTGEL CAPSULE MARKET BY APPLICATION (2017-2032)
   1. SOFTGEL CAPSULE MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. ANTIBIOTIC DRUGS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2032F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2032F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. CARDIOVASCULAR DRUGS
   5. ANTI-INFLAMMATORY DRUGS
   6. HEALTH SUPPLEMENTS
9. COMPANY PROFILES AND COMPETITIVE ANALYSIS
   1. COMPETITIVE LANDSCAPE
      1. Competitive Positioning
      2. SOFTGEL CAPSULE Market Share By Manufacturer (2023)
      3. Industry BCG Matrix
      4. Heat Map Analysis
      5. Mergers & Acquisitions
   2. CATALANT INC. (USA)
      1. Company Overview
      2. Key Executives
      3. Company Snapshot
      4. Role of the Company in the Market
      5. Sustainability and Social Responsibility
      6. Operating Business Segments
      7. Product Portfolio
      8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
      9. Key Strategic Moves And Recent Developments
      10. SWOT Analysis
   3. BEST FORMULATIONS INC. (USA)
   4. AMNEAL PHARMACEUTICALS (USA)
   5. CAPSUGEL (LONZA) (USA)
   6. ROBINSON PHARMA INC. (USA)
   7. THERMOFISHER SCIENTIFIC INC. (USA)
   8. CAPTEK SOFTGEL INTERNATIONAL INC. (USA)
   9. ROQUETTE (FRANCE)
   10. CURTIS HEALTH CAPS (POLAND)
   11. DCC PLC. (IRELAND)
   12. PROCAPS GROUPS (COLOMBIA)
   13. AENOVA GROUP (GERMANY)
   14. PB LEINER (GERMANY)
   15. FUJI CAPSULE CO., LTD. (JAPAN)
   16. SIRIO PHARMA CO. (CHINA)
10. GLOBAL SOFTGEL CAPSULE MARKET BY REGION
    1. OVERVIEW
    2. NORTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Product Type
       4. Historic And Forecasted Market Size By Source Type
       5. Historic And Forecasted Market Size By Application
       6. Historic And Forecasted Market Size By Country
          1. USA
          2. Canada
          3. Mexico
    3. EASTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Russia
          2. Bulgaria
          3. The Czech Republic
          4. Hungary
          5. Poland
          6. Romania
          7. Rest Of Eastern Europe
    4. WESTERN EUROPE
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Germany
          2. United Kingdom
          3. France
          4. The Netherlands
          5. Italy
          6. Spain
          7. Rest Of Western Europe
    5. ASIA PACIFIC
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. China
          2. India
          3. Japan
          4. South Korea
          5. Malaysia
          6. Thailand
          7. Vietnam
          8. The Philippines
          9. Australia
          10. New-Zealand
          11. Rest Of APAC
    6. MIDDLE EAST & AFRICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Turkey
          2. Bahrain
          3. Kuwait
          4. Saudi Arabia
          5. Qatar
          6. UAE
          7. Israel
          8. South Africa
    7. SOUTH AMERICA
       1. Key Market Trends, Growth Factors And Opportunities
       2. Key Manufacturers
       3. Historic And Forecasted Market Size By Segments
       4. Historic And Forecasted Market Size By Country
          1. Brazil
          2. Argentina
          3. Rest of South America
11. INVESTMENT ANALYSIS
12. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. SOFTGEL CAPSULE MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. SOFTGEL CAPSULE MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. SOFTGEL CAPSULE MARKET COMPETITIVE RIVALRY
TABLE 005. SOFTGEL CAPSULE MARKET THREAT OF NEW ENTRANTS
TABLE 006. SOFTGEL CAPSULE MARKET THREAT OF SUBSTITUTES
TABLE 007. SOFTGEL CAPSULE MARKET BY TYPE
TABLE 008. GELATIN TYPE MARKET OVERVIEW (2016-2028)
TABLE 009. NON-ANIMAL TYPE MARKET OVERVIEW (2016-2028)
TABLE 010. SOFTGEL CAPSULE MARKET BY APPLICATION
TABLE 011. NUTRITIONAL MARKET OVERVIEW (2016-2028)
TABLE 012. OVER THE COUNTER (OTC) MARKET OVERVIEW (2016-2028)
TABLE 013. PRESCRIPTION (RX) MARKET OVERVIEW (2016-2028)
TABLE 014. NORTH AMERICA SOFTGEL CAPSULE MARKET, BY TYPE (2016-2028)
TABLE 015. NORTH AMERICA SOFTGEL CAPSULE MARKET, BY APPLICATION (2016-2028)
TABLE 016. N SOFTGEL CAPSULE MARKET, BY COUNTRY (2016-2028)
TABLE 017. EUROPE SOFTGEL CAPSULE MARKET, BY TYPE (2016-2028)
TABLE 018. EUROPE SOFTGEL CAPSULE MARKET, BY APPLICATION (2016-2028)
TABLE 019. SOFTGEL CAPSULE MARKET, BY COUNTRY (2016-2028)
TABLE 020. ASIA PACIFIC SOFTGEL CAPSULE MARKET, BY TYPE (2016-2028)
TABLE 021. ASIA PACIFIC SOFTGEL CAPSULE MARKET, BY APPLICATION (2016-2028)
TABLE 022. SOFTGEL CAPSULE MARKET, BY COUNTRY (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA SOFTGEL CAPSULE MARKET, BY TYPE (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA SOFTGEL CAPSULE MARKET, BY APPLICATION (2016-2028)
TABLE 025. SOFTGEL CAPSULE MARKET, BY COUNTRY (2016-2028)
TABLE 026. SOUTH AMERICA SOFTGEL CAPSULE MARKET, BY TYPE (2016-2028)
TABLE 027. SOUTH AMERICA SOFTGEL CAPSULE MARKET, BY APPLICATION (2016-2028)
TABLE 028. SOFTGEL CAPSULE MARKET, BY COUNTRY (2016-2028)
TABLE 029. CATALENT: SNAPSHOT
TABLE 030. CATALENT: BUSINESS PERFORMANCE
TABLE 031. CATALENT: PRODUCT PORTFOLIO
TABLE 032. CATALENT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 032. AENOVA: SNAPSHOT
TABLE 033. AENOVA: BUSINESS PERFORMANCE
TABLE 034. AENOVA: PRODUCT PORTFOLIO
TABLE 035. AENOVA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 035. PROCAPS: SNAPSHOT
TABLE 036. PROCAPS: BUSINESS PERFORMANCE
TABLE 037. PROCAPS: PRODUCT PORTFOLIO
TABLE 038. PROCAPS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. PATHEON: SNAPSHOT
TABLE 039. PATHEON: BUSINESS PERFORMANCE
TABLE 040. PATHEON: PRODUCT PORTFOLIO
TABLE 041. PATHEON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. IVC: SNAPSHOT
TABLE 042. IVC: BUSINESS PERFORMANCE
TABLE 043. IVC: PRODUCT PORTFOLIO
TABLE 044. IVC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. EUROCAPS: SNAPSHOT
TABLE 045. EUROCAPS: BUSINESS PERFORMANCE
TABLE 046. EUROCAPS: PRODUCT PORTFOLIO
TABLE 047. EUROCAPS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. CAPTEK: SNAPSHOT
TABLE 048. CAPTEK: BUSINESS PERFORMANCE
TABLE 049. CAPTEK: PRODUCT PORTFOLIO
TABLE 050. CAPTEK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. STRIDES ARCOLAB: SNAPSHOT
TABLE 051. STRIDES ARCOLAB: BUSINESS PERFORMANCE
TABLE 052. STRIDES ARCOLAB: PRODUCT PORTFOLIO
TABLE 053. STRIDES ARCOLAB: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. CAPSUGEL: SNAPSHOT
TABLE 054. CAPSUGEL: BUSINESS PERFORMANCE
TABLE 055. CAPSUGEL: PRODUCT PORTFOLIO
TABLE 056. CAPSUGEL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. NBTY: SNAPSHOT
TABLE 057. NBTY: BUSINESS PERFORMANCE
TABLE 058. NBTY: PRODUCT PORTFOLIO
TABLE 059. NBTY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. SOFT GEL TECHNOLOGIES: SNAPSHOT
TABLE 060. SOFT GEL TECHNOLOGIES: BUSINESS PERFORMANCE
TABLE 061. SOFT GEL TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 062. SOFT GEL TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 062. AMWAY: SNAPSHOT
TABLE 063. AMWAY: BUSINESS PERFORMANCE
TABLE 064. AMWAY: PRODUCT PORTFOLIO
TABLE 065. AMWAY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 065. SIRIO PHARMA: SNAPSHOT
TABLE 066. SIRIO PHARMA: BUSINESS PERFORMANCE
TABLE 067. SIRIO PHARMA: PRODUCT PORTFOLIO
TABLE 068. SIRIO PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 068. BAIHE BIOTECH: SNAPSHOT
TABLE 069. BAIHE BIOTECH: BUSINESS PERFORMANCE
TABLE 070. BAIHE BIOTECH: PRODUCT PORTFOLIO
TABLE 071. BAIHE BIOTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 071. ZIGUANG GROUP: SNAPSHOT
TABLE 072. ZIGUANG GROUP: BUSINESS PERFORMANCE
TABLE 073. ZIGUANG GROUP: PRODUCT PORTFOLIO
TABLE 074. ZIGUANG GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 074. SHINEWAY: SNAPSHOT
TABLE 075. SHINEWAY: BUSINESS PERFORMANCE
TABLE 076. SHINEWAY: PRODUCT PORTFOLIO
TABLE 077. SHINEWAY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 077. DONGHAI PHARM: SNAPSHOT
TABLE 078. DONGHAI PHARM: BUSINESS PERFORMANCE
TABLE 079. DONGHAI PHARM: PRODUCT PORTFOLIO
TABLE 080. DONGHAI PHARM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 080. BY-HEALTH: SNAPSHOT
TABLE 081. BY-HEALTH: BUSINESS PERFORMANCE
TABLE 082. BY-HEALTH: PRODUCT PORTFOLIO
TABLE 083. BY-HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 083. YUWANG GROUP: SNAPSHOT
TABLE 084. YUWANG GROUP: BUSINESS PERFORMANCE
TABLE 085. YUWANG GROUP: PRODUCT PORTFOLIO
TABLE 086. YUWANG GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 086. GUANGDONG YICHAO: SNAPSHOT
TABLE 087. GUANGDONG YICHAO: BUSINESS PERFORMANCE
TABLE 088. GUANGDONG YICHAO: PRODUCT PORTFOLIO
TABLE 089. GUANGDONG YICHAO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 089. XIAMEN XGMA: SNAPSHOT
TABLE 090. XIAMEN XGMA: BUSINESS PERFORMANCE
TABLE 091. XIAMEN XGMA: PRODUCT PORTFOLIO
TABLE 092. XIAMEN XGMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 092. GUANGDONG MINGWEI: SNAPSHOT
TABLE 093. GUANGDONG MINGWEI: BUSINESS PERFORMANCE
TABLE 094. GUANGDONG MINGWEI: PRODUCT PORTFOLIO
TABLE 095. GUANGDONG MINGWEI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 095. HUIDA HEAVY: SNAPSHOT
TABLE 096. HUIDA HEAVY: BUSINESS PERFORMANCE
TABLE 097. HUIDA HEAVY: PRODUCT PORTFOLIO
TABLE 098. HUIDA HEAVY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 098. HEBEI HONGTAI: SNAPSHOT
TABLE 099. HEBEI HONGTAI: BUSINESS PERFORMANCE
TABLE 100. HEBEI HONGTAI: PRODUCT PORTFOLIO
TABLE 101. HEBEI HONGTAI: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101. LIANGSHAN TONGYA: SNAPSHOT
TABLE 102. LIANGSHAN TONGYA: BUSINESS PERFORMANCE
TABLE 103. LIANGSHAN TONGYA: PRODUCT PORTFOLIO
TABLE 104. LIANGSHAN TONGYA: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. SOFTGEL CAPSULE MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. SOFTGEL CAPSULE MARKET OVERVIEW BY TYPE
FIGURE 012. GELATIN TYPE MARKET OVERVIEW (2016-2028)
FIGURE 013. NON-ANIMAL TYPE MARKET OVERVIEW (2016-2028)
FIGURE 014. SOFTGEL CAPSULE MARKET OVERVIEW BY APPLICATION
FIGURE 015. NUTRITIONAL MARKET OVERVIEW (2016-2028)
FIGURE 016. OVER THE COUNTER (OTC) MARKET OVERVIEW (2016-2028)
FIGURE 017. PRESCRIPTION (RX) MARKET OVERVIEW (2016-2028)
FIGURE 018. NORTH AMERICA SOFTGEL CAPSULE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. EUROPE SOFTGEL CAPSULE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. ASIA PACIFIC SOFTGEL CAPSULE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. MIDDLE EAST & AFRICA SOFTGEL CAPSULE MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. SOUTH AMERICA SOFTGEL CAPSULE MARKET OVERVIEW BY COUNTRY (2016-2028)